Pharmafile Logo
Pharmafocus logo
Advanced Search

Daiichi

Showing 11 posts of 11 posts found.

sign-web

Daiichi Sankyo rocked by further job losses

December 9, 2015
Manufacturing and Production Daiichi, Daiichi Sankyo

The Japanese pharma firm Daiichi Sankyo is to close an antibody-producing subsidiary in Germany, as the company continues to cut …

Appointment
Daiichi Sankyo

Daiichi sheds more US jobs as generic losses take their toll

October 20, 2015
Daiichi, Daiichi Sankyo, generic competition, generics, job losses, patent cliff, patents, redundancies

The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …

News
Daiichi Sankyo

Daiichi scores another NICE nod for Lixiana

August 12, 2015
Sales and Marketing Daichii Sankyo, Daiichi, Lixiana, atrial fibrillation, edoxaban

NICE has recommended in draft guidance the anti-blood clotting drug Daiichi Sankyo’s Lixiana for preventing stroke and blood clots in …

News
Daiichi Sankyo

NICE recommends Daiichi’s Lixiana for blood clots

July 13, 2015
Sales and Marketing DVT, Daiichi, Daiichi Sankyo, Lixiana, NICE, NOACs, VTE, anticoagulant, blood clots, edoxaban, novel anticoagulant. PE

Daiichi Sankyo has won a speedy approval from NICE, after the NHS guidance body approved its newly-launched blood clotting drug …

News
sun pharma image

Sun Pharma sacks 18 Ranbaxy executives

June 19, 2015
Manufacturing and Production, Sales and Marketing Daiichi, India, Ranbaxy, Sun Pharma, brett wells

Sun Pharma has asked 18 executives to leave the company who were previously a part of Ranbaxy, the firm it …

News
Eisai image

Eisai cuts 25% of US staff

April 10, 2015
Medical Communications, Research and Development, Sales and Marketing Daiichi, Eisai, US, cuts, layoffs, reorganisation, staff

Eisai’s US business is offloading around 200 jobs as part of some restructuring to create a more ‘efficient and focussed …

News
Daiichi image

AstraZeneca and Daiichi team up for constipation drug

March 19, 2015
Sales and Marketing AstraZeneca, Daiichi, Movantik, constipation, naloxegol, oic

AstraZeneca and Daiichi Sankyo have signed a deal worth around $825 million to jointly commercialise constipation drug Movantik in the …

News

Daiichi’s lung cancer drug progresses to phase III

August 5, 2010
Research and Development Daiichi, arq 197, arqule, lung cancer, phase III

Daiichi Sankyo and biotech firm Arqule are to move their lung cancer treatment ARQ 197 into phase III trials. The …

News

Efient launched in the UK

April 9, 2009
Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo's blood-thinning drug Efient has been launched in the UK for heart attack patients, taking on blockbuster …

News

Europe approves Lilly’s Plavix rival

February 25, 2009
Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …

News

Daiichi Sankyo sets up Ireland operations

November 27, 2008
Sales and Marketing Daiichi, Ireland

Japanese company Daiichi Sankyo is continuing its expansion in Europe with the launch of operations in Ireland.The new subsidiary's headquarters …

News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024